Topical Antibiotic

CLINDEX GEL

Clindamycin Phosphate

Strength
1 % w/w
Dosage form
Gel
Pack size
15 g
Packing
Tube
CLINDEX GEL

Product information

QUANTITATIVE COMPOSITION

Each gram of gel contains 10 mg of clindamycin (as clindamycin phosphate), equivalent to 1.0% w/w.
Topical gel

CLINICAL PARTICULARS

Therapeutic Indications

Topical treatment of inflammatory lesions of acne vulgaris, such as papules and pustules, especially when caused by Propionibacterium acnes (Cutibacterium acnes).

Posology and method of administration

Posology:

  • Adults and adolescents aged 12 years and older: Apply a thin layer of gel once or twice daily to the affected skin areas.
  • Treatment duration: Usually 8 to 12 weeks; prolonged use should be under medical supervision.

Special Populations:

  • Children under 12 years: Safety and efficacy not established; use only under medical advice.
Method of Administration
  • For external use only.
  • Apply gently and avoid contact with eyes, mouth, and other mucous membranes.
  • Wash hands before and after application unless hands are being treated.
Contraindications
  • Hypersensitivity to clindamycin, lincomycin, or any excipients.
  • History of antibiotic-associated colitis.
  • Use on broken or inflamed skin (except acne lesions).
Special warnings and precautions for use
  • Use with caution in patients with a history of gastrointestinal disease, particularly colitis.
  • Discontinue if severe diarrhea or signs of pseudomembranous colitis occur.
  • Avoid concomitant systemic antibiotic use with clindamycin unless prescribed by a physician.
  • Avoid use near eyes or mucous membranes.
  • Prolonged use may cause overgrowth of non-susceptible organisms, including fungi.
Interaction with other medicinal products and other forms of interaction
  • No significant systemic interactions expected with topical use.
  • Avoid concomitant topical or systemic antibiotics with overlapping spectra unless directed by a physician.
Fertility, Pregnancy and Lactation
  • Pregnancy: Use only if clearly needed after risk-benefit assessment.
  • Lactation: Limited data; use with caution, avoid nipple areas during breastfeeding.
Effects on ability to drive and use machines
  • No effect expected.
Undesirable Effects

Very Common (≥1/10)

Common (≥1/100 to <1/10)

Uncommon (≥1/1,000 to <1/100)

Rare (<1/1,000)

Local Skin Irritation, Dryness, Peeling, Burning Sensation

Erythema, Itching, Rash

Contact Dermatitis

Hypersensitivity Reactions

  • Usually mild and transient.
Overdose
  • Topical overdose is unlikely to cause systemic toxicity.
  • In case of excessive application, wash the area with water and discontinue use.
  • Seek medical advice if symptoms develop.
PHARMACOLOGICAL PROPERTIES

Pharmacodynamic Properties

  • Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
  • Active against Cutibacterium acne and other Gram-positive bacteria implicated in acne.
Pharmacokinetic properties
  • Minimal systemic absorption after topical application; peak plasma levels generally undetectable.
Special precautions for storage
  • Store below 25°C.
  • Keep tube tightly closed.